| ■ 영문 제목 : Global Plasma Protein Therapeutics Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02150 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 106 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 혈장 단백질 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (응고 인자, 면역 글로불린, 알부민, 기타)와 용도별 시장규모 (혈우병, PID, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 혈장 단백질 치료제 시장 점유율 - 지역별 혈장 단백질 치료제 시장규모 - 주요지역의 종류별 시장규모 (응고 인자, 면역 글로불린, 알부민, 기타) - 주요지역의 용도별 시장규모 (혈우병, PID, 기타) - 미주의 혈장 단백질 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 혈장 단백질 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 혈장 단백질 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 혈장 단백질 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 혈장 단백질 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Kamada - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Plasma Protein Therapeutics will have significant change from previous year. By the most conservative estimates of global Plasma Protein Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 25710 million in 2020. Over the next five years the Plasma Protein Therapeutics market will register a 7.1% CAGR in terms of revenue, the global market size will reach US$ 33770 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Protein Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Coagulation Factor
Immune Globulin
Albumin
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hemophilia
PID
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
1 Scope of the Report 2 Executive Summary 3 Global Plasma Protein Therapeutics by Company 4 Plasma Protein Therapeutics by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Plasma Protein Therapeutics Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Plasma Protein Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Coagulation Factor Table 3. Major Players of Immune Globulin Table 4. Major Players of Albumin Table 5. Major Players of Others Table 6. Global Plasma Protein Therapeutics Sales by Type (2016-2021) & (K Units) Table 7. Global Plasma Protein Therapeutics Sales Market Share by Type (2016-2021) Table 8. Global Plasma Protein Therapeutics Revenue by Type (2016-2021) & ($ million) Table 9. Global Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021) Table 10. Global Plasma Protein Therapeutics Sale Price by Type (2016-2021) Table 11. Global Plasma Protein Therapeutics Sales by Application (2016-2021) & (K Units) Table 12. Global Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Table 13. Global Plasma Protein Therapeutics Value by Application (2016-2021) Table 14. Global Plasma Protein Therapeutics Revenue Market Share by Application (2016-2021) Table 15. Global Plasma Protein Therapeutics Sale Price by Application (2016-2021) Table 16. Global Plasma Protein Therapeutics Sales by Company (2019-2021) & (K Units) Table 17. Global Plasma Protein Therapeutics Sales Market Share by Company (2019-2021) Table 18. Global Plasma Protein Therapeutics Revenue by Company (2019-2021) ($ Millions) Table 19. Global Plasma Protein Therapeutics Revenue Market Share by Company (2019-2021) Table 20. Global Plasma Protein Therapeutics Sale Price by Company (2019-2021) Table 21. Key Manufacturers Plasma Protein Therapeutics Producing Area Distribution and Sales Area Table 22. Players Plasma Protein Therapeutics Products Offered Table 23. Plasma Protein Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Plasma Protein Therapeutics Sales by Region (2016-2021) (K Units) Table 27. Global Plasma Protein Therapeutics Sales Market Share by Region (2016-2021) Table 28. Global Plasma Protein Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Plasma Protein Therapeutics Revenue Market Share by Region (2016-2021) Table 30. Americas Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units) Table 31. Americas Plasma Protein Therapeutics Sales Market Share by Country (2016-2021) Table 32. Americas Plasma Protein Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021) Table 34. Americas Plasma Protein Therapeutics Sales by Type (2016-2021) & (K Units) Table 35. Americas Plasma Protein Therapeutics Sales Market Share by Type (2016-2021) Table 36. Americas Plasma Protein Therapeutics Sales by Application (2016-2021) & (K Units) Table 37. Americas Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Table 38. APAC Plasma Protein Therapeutics Sales by Region (2016-2021) & (K Units) Table 39. APAC Plasma Protein Therapeutics Sales Market Share by Region (2016-2021) Table 40. APAC Plasma Protein Therapeutics Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Plasma Protein Therapeutics Revenue Market Share by Region (2016-2021) Table 42. APAC Plasma Protein Therapeutics Sales by Type (2016-2021) & (K Units) Table 43. APAC Plasma Protein Therapeutics Sales Market Share by Type (2016-2021) Table 44. APAC Plasma Protein Therapeutics Sales by Application (2016-2021) & (K Units) Table 45. APAC Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Table 46. Europe Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units) Table 47. Europe Plasma Protein Therapeutics Sales Market Share by Country (2016-2021) Table 48. Europe Plasma Protein Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021) Table 50. Europe Plasma Protein Therapeutics Sales by Type (2016-2021) & (K Units) Table 51. Europe Plasma Protein Therapeutics Sales Market Share by Type (2016-2021) Table 52. Europe Plasma Protein Therapeutics Sales by Application (2016-2021) & (K Units) Table 53. Europe Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa Plasma Protein Therapeutics Sales by Country (2016-2021) & (K Units) Table 55. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Plasma Protein Therapeutics Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Plasma Protein Therapeutics Sales by Type (2016-2021) & (K Units) Table 59. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa Plasma Protein Therapeutics Sales by Application (2016-2021) & (K Units) Table 61. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Table 62. Key and Potential Regions of Plasma Protein Therapeutics Table 63. Key Application and Potential Industries of Plasma Protein Therapeutics Table 64. Key Challenges of Plasma Protein Therapeutics Table 65. Key Trends of Plasma Protein Therapeutics Table 66. Plasma Protein Therapeutics Distributors List Table 67. Plasma Protein Therapeutics Customer List Table 68. Global Plasma Protein Therapeutics Sales Forecast by Region (2021-2026) & (K Units) Table 69. Global Plasma Protein Therapeutics Consumption Market Forecast by Region Table 70. Global Plasma Protein Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Plasma Protein Therapeutics Sales Forecast by Country (2021-2026) & (K Units) Table 73. Americas Plasma Protein Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Plasma Protein Therapeutics Sales Forecast by Region (2021-2026) & (K Units) Table 75. APAC Plasma Protein Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Plasma Protein Therapeutics Sales Forecast by Country (2021-2026) & (K Units) Table 77. Europe Plasma Protein Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Plasma Protein Therapeutics Sales Forecast by Country (2021-2026) & (K Units) Table 79. Middle East & Africa Plasma Protein Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Plasma Protein Therapeutics Sales Forecast by Type (2021-2026) & (K Units) Table 81. Global Plasma Protein Therapeutics Sales Market Share Forecast by Type (2021-2026) Table 82. Global Plasma Protein Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions) Table 83. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Type (2021-2026) Table 84. Global Plasma Protein Therapeutics Sales Forecast by Application (2021-2026) & (K Units) Table 85. Global Plasma Protein Therapeutics Sales Market Share Forecast by Application (2021-2026) Table 86. Global Plasma Protein Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions) Table 87. Global Plasma Protein Therapeutics Revenue Market Share Forecast by Application (2021-2026) Table 88. Shire (Baxalta) Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 89. Shire (Baxalta) Plasma Protein Therapeutics Product Offered Table 90. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 91. Shire (Baxalta) Main Business Table 92. Shire (Baxalta) Latest Developments Table 93. CSL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 94. CSL Plasma Protein Therapeutics Product Offered Table 95. CSL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 96. CSL Main Business Table 97. CSL Latest Developments Table 98. Grifols Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 99. Grifols Plasma Protein Therapeutics Product Offered Table 100. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 101. Grifols Main Business Table 102. Grifols Latest Developments Table 103. Octapharma Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 104. Octapharma Plasma Protein Therapeutics Product Offered Table 105. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 106. Octapharma Main Business Table 107. Octapharma Latest Developments Table 108. Kedrion Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 109. Kedrion Plasma Protein Therapeutics Product Offered Table 110. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 111. Kedrion Main Business Table 112. Kedrion Latest Developments Table 113. LFB Group Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 114. LFB Group Plasma Protein Therapeutics Product Offered Table 115. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 116. LFB Group Main Business Table 117. LFB Group Latest Developments Table 118. Biotest Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 119. Biotest Plasma Protein Therapeutics Product Offered Table 120. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 121. Biotest Main Business Table 122. Biotest Latest Developments Table 123. BPL Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 124. BPL Plasma Protein Therapeutics Product Offered Table 125. BPL Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 126. BPL Main Business Table 127. BPL Latest Developments Table 128. RAAS Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 129. RAAS Plasma Protein Therapeutics Product Offered Table 130. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 131. RAAS Main Business Table 132. RAAS Latest Developments Table 133. CBPO Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 134. CBPO Plasma Protein Therapeutics Product Offered Table 135. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 136. CBPO Main Business Table 137. CBPO Latest Developments Table 138. Hualan Bio Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 139. Hualan Bio Plasma Protein Therapeutics Product Offered Table 140. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 141. Hualan Bio Main Business Table 142. Hualan Bio Latest Developments Table 143. Kamada Basic Information, Plasma Protein Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 144. Kamada Plasma Protein Therapeutics Product Offered Table 145. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 146. Kamada Main Business Table 147. Kamada Latest Developments List of Figures Figure 1. Picture of Plasma Protein Therapeutics Figure 2. Plasma Protein Therapeutics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Plasma Protein Therapeutics Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Plasma Protein Therapeutics Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Plasma Protein Therapeutics Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Coagulation Factor Figure 10. Product Picture of Immune Globulin Figure 11. Product Picture of Albumin Figure 12. Product Picture of Others Figure 13. Global Plasma Protein Therapeutics Sales Market Share by Type in 2020 Figure 14. Global Plasma Protein Therapeutics Revenue Market Share by Type (2016-2021) Figure 15. Plasma Protein Therapeutics Consumed in Hemophilia Figure 16. Global Plasma Protein Therapeutics Market: Hemophilia (2016-2021) & (K Units) Figure 17. Plasma Protein Therapeutics Consumed in PID Figure 18. Global Plasma Protein Therapeutics Market: PID (2016-2021) & (K Units) Figure 19. Plasma Protein Therapeutics Consumed in Others Figure 20. Global Plasma Protein Therapeutics Market: Others (2016-2021) & (K Units) Figure 21. Global Plasma Protein Therapeutics Sales Market Share by Application (2016-2021) Figure 22. Global Plasma Protein Therapeutics Revenue Market Share by Application in 2020 Figure 23. Plasma Protein Therapeutics Revenue Market by Company in 2020 ($ Million) Figure 24. Global Plasma Protein Therapeutics Revenue Market Share by Company in 2020 Figure 25. Global Plasma Protein Therapeutics Sales Market Share by Regions (2016-2021) Figure 26. Global Plasma Protein Therapeutics Revenue Market Share by Region in 2020 Figure 27. Americas Plasma Protein Therapeutics Sales 2016-2021 (K Units) Figure 28. Americas Plasma Protein Therapeutics Revenue 2016-2021 ($ Millions) Figure 29. APAC Plasma Protein Therapeutics Sales 2016-2021 (K Units) Figure 30. APAC Plasma Protein Therapeutics Revenue 2016-2021 ($ Millions) Figure 31. Europe Plasma Protein Therapeutics Sales 2016-2021 (K Units) Figure 32. Europe Plasma Protein Therapeutics Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa Plasma Protein Therapeutics Sales 2016-2021 (K Units) Figure 34. Middle East & Africa Plasma Protein Therapeutics Revenue 2016-2021 ($ Millions) Figure 35. Americas Plasma Protein Therapeutics Sales Market Share by Country in 2020 Figure 36. Americas Plasma Protein Therapeutics Revenue Market Share by Country in 2020 Figure 37. Americas Plasma Protein Therapeutics Sales Market Share by Type in 2020 Figure 38. Americas Plasma Protein Therapeutics Sales Market Share by Application in 2020 Figure 39. United States Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC Plasma Protein Therapeutics Sales Market Share by Region in 2020 Figure 44. APAC Plasma Protein Therapeutics Revenue Market Share by Regions in 2020 Figure 45. APAC Plasma Protein Therapeutics Sales Market Share by Type in 2020 Figure 46. APAC Plasma Protein Therapeutics Sales Market Share by Application in 2020 Figure 47. China Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 51. India Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe Plasma Protein Therapeutics Sales Market Share by Country in 2020 Figure 54. Europe Plasma Protein Therapeutics Revenue Market Share by Country in 2020 Figure 55. Europe Plasma Protein Therapeutics Sales Market Share by Type in 2020 Figure 56. Europe Plasma Protein Therapeutics Sales Market Share by Application in 2020 Figure 57. Germany Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 58. France Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 59. UK Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Country in 2020 Figure 63. Middle East & Africa Plasma Protein Therapeutics Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Type in 2020 Figure 65. Middle East & Africa Plasma Protein Therapeutics Sales Market Share by Application in 2020 Figure 66. Egypt Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country Plasma Protein Therapeutics Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles |
| ※본 조사보고서 [세계의 혈장 단백질 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02150) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 혈장 단백질 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |